Document:

Exhibit 10.7.1 Amendment to Exclusive Distribution agreement

EXHIBIT 10.7.1

* Certain portions of this exhibit have been omitted pursuant to a request for confidential
treatment which has been filed separately with the SEC
 
FIRST AMENDMENT TO
EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN

CUMBERLAND PHARMACEUTICALS, Inc.
AND
CARDINAL HEALTH 105, INC.

This Amendment to the Exclusive Distribution Agreement (“First Amendment”) is made as of March 31, 2013 (“Effective Date”), by and between Cumberland Pharmaceuticals, Inc., a Tennessee corporation, with an address of 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 15 Ingram Boulevard, Suite 100, LaVergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).

RECITALS

WHEREAS Cardinal Health and Client are Parties to an Exclusive Distribution Agreement dated (“Effective Date”) as of July 1, 2010 (“Agreement”) and the Parties desire to amend the Agreement as provided in this First Amendment; and

WHEREAS Client wishes to engage Cardinal Health to assist with their physician sample orders based on the Prescription Drug Marketing Act of 1987 for samples shipping; and

WHEREAS, the Parties mutually agree to amend the Agreement including (Exhibit A) Opertaing Guidelines and (Exhibit B) Fee Schedule.

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this First Amendment, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree that the Agreement is hereby amended as follows:  
1.  Amendment to Section 5.1 of the Agreement.  In Section 5.1 of the Agreement is deleted in its entirety and is replaced with the following language:
5.1   Fees.  As compensation for the Services, Client shall pay to Cardinal Health the fees (“Fees”) set forth in Exhibit B-2 (“Fee Schedule”) attached hereto and incorporated by reference.

2.    Amendment to Section 6.1 of the Agreement.  Section 6.1 of the Agreement, is deleted in its entirety and shall be replaced with the following:

6.1     Term.  The Initial term of this Agreement shall begin on the Effective Date and shall continue through June 30, 2016 (“Initial Term”) unless terminated earlier pursuant to this Agreement. Thereafter, this Agreement shall automatically renew for additional terms of one (1) year each (each, a “Renewal Term,” and together with the Initial Term, the “Term”), unless written notice of termination is given by either Party at least ninety (90) days prior to the end of the Initial Term or such other term, in which case this Agreement shall terminate at the end of the then current term.

3.    Amendment to Section 1.0 of Exhibit A (Operating Guidelines) related to Warehousing.  The following section shall be added to Section 1.0 of the Operating Guidelines:

1.1(a)    With reference to those regulations set forth in 21 CFR Part 203, Cardinal Health will support Client's programs directed to compliance with the Prescription Drug Marketing Act of 1987 (“PDMA”) provisions related to acceptance of valid sample requests, validation of practitioner's license status, inventory, storage, distribution, shipment, retrieval of acknowledgement of contents, response to practitioner patterns of non-response, signature verification, document controls and record retention, and other services performed on behalf of the Client to maintain PDMA compliance.   Other aspects of compliance with the PDMA, such as providing Product labeled specifically for sampling, forwarding requests for samples to Cardinal Health and interacting with regulatory authorities, will remain the sole responsibility of the Client.

4.    Amendment to Section 5.0 of Exhibit A (Operating Guidelines) related to Distribution.  The following section shall be added to Section 6 of the Operating Guidelines:

5.16    Please Note.  Responsibility for verifying and submitting order forms for physician sample orders will remain the sole responsibility of the Client. Additionally, Cardinal Health will contact the Client to resolve discrepancies identified on the order forms that have been submitted for Physician sample orders.

5.    Amendment to Section 23.0 (Records Retention) of Exhibit A (Operating Guidelines) of the Agreement.  The Records Retention Schedule in Section 23.0 of Exhibit A is deleted in its entirety and replaced with the following:
RECORD RETENTION SCHEDULE

	
			
	Document Type
	Document Retention Period
	Storage Method

	I. Customer Service
	 
	 

	Customer order records
	7 years
	Cabinet/boxed/Electronic file

	Patient Assistance Orders
	10 years
	Locked cabinet

	Price Notifications
	6 years
	Cabinet/boxed/analyst

	Adverse Events Notifications
	10 years
	Electronic file

	Freight Claims
	7 years
	Electronic file

	Bills of Lading
	5 years
	Cabinet/boxed

	Customer Set-up & Maintenance
	7 years
	Electronic file

	PAP Customer Set-Up
	10 years
	Locked cabinet

	Invoice Adjustments
	7 years
	Cabinet/boxed

	Document Type
	Document Retention Period
	Storage Method

	II. Accounts Receivable
	 
	 

	Customer Invoices
	7 years
	Cabinet/boxed

	Invoice collection documentation
	7 years
	Electronic file

	Cash Receipts
	7 years
	Cabinet/boxed/Electronic file

	Deduction documentation/resolution
	7 years
	Cabinet/boxed/Electronic file

	Month end Close Records
	7 years
	Cabinet/boxed/Electronic file

	Related correspondence
	7 years
	Cabinet/boxed/Electronic file

	
			
	Document Type
	Document Retention Period
	Storage Method

	III. Returns Management
	 
	 

	Return Authorizations
	10 years
	Cabinet/boxed/daily folder/Electronic file

	Return paperwork & credit memo
	10 years
	Cabinet/boxed/daily folder/Electronic file

	Related correspondence
	10 years
	Cabinet/boxed/daily folder/Electronic file

	Return Policy
	6 years
	Cabinet/boxed/Electronic file

	Pricing Notification
	10 years
	Cabinet/boxed/Electronic file

	 
	 
	 

	IV. Contracts & Chargebacks
	 
	 

	Contract Set-up/Contract Change
	10 years
	Cabinet/boxed

	Contract Price Changes
	10 years
	Cabinet/boxed

	Pricing Notifications
	10 years
	Cabinet/boxed

	Chargeback Submissions
	10 years
	Cabinet/boxed

	Chargeback Rejections
	10 years
	Cabinet/boxed

	Credit Feed Report
	10 years
	Cabinet/boxed

	Membership Rosters
	10 years
	Cabinet/boxed

	Membership changes/notifications
	10 years
	Cabinet/boxed

6.    Amendment to Exhibit B (Fee Scehdule) of the Agreement.  Exhibit B of the Agreement dated January 5, 2010 is deleted in its entirety and replaced with the attached Exhibit-B2 dated April 1, 2013.

7.    No Other Changes.  Except as specifically set forth in this First Amendment, the Agreement will continue in full force and effect without change.

8.     Interpretation.  To the extent there are any inconsistencies between the provisions of this First Amendment and the provisions of the Agreement, the provisions of this First Amendment will control.  Capitalized terms not otherwise defined herein shall have the same meaning given those terms in the Agreement, it being the intent of the Parties that the Agreement and this First Amendment will be applied and construed as a single instrument.  The Agreement, as modified by this First Amendment, constitutes the entire agreement between Cardinal Health and Client regarding the subject matter of this First Amendment and supersedes all prior or contemporaneous writings and understandings between the Parties regarding the same.

9.     Counterparts.  This Amendment may be executed in one or more counterparts (with facsimile signatures acceptable), each of which shall be deemed an original but all of which together shall constitute one and the same instrument.    
10.      Authorized Signatories.  All signatories to this First Amendment represent that they are authorized by their respective companies to execute and deliver this Amendment on behalf of their respective companies, and to bind such companies to the terms herein.

IN WITNESS WHEREOF, the Parties hereto have agreed to this First Amendment by having their duly authorized representative execute this Amendment effective as of the 1st day of April, 2013. 

	
			
	CARDINAL HEALTH 105, INC.
	 
	CUMBERLAND PHARMACEUTICALS, Inc.

	 
	 
	 

	By: /s/ Sanjeeth Pai
	 
	By: /s/ Rick S. Greene

	Print Name: Sanjeeth Pai
	 
	Print Name: Rick S. Greene

	Title: Vice President
	 
	Title: VP & CFO

	Date: 5/22/13
	 
	Date: 5/20/13

	 
	 
	 

	 
	 
	 

<Signature Page to First Amendment>

CUMBERLAND PHARMACEUTICALS
EXHIBIT B-2
FEE SCHEDULE
Effective April 1, 2013
	
					
	 
	 
	 
	 
	 

	Program Implementation
	 
	 
	 
	 

	Line Extension Fee (3)
	 
	$ [***]
	 
	 

	Distribution Services
	 
	 
	 
	 

	Storage Fee
	 
	 
	 
	 

	Ambient storage fee (5)
	 
	$ [***]
	 
	Per pallet per month

	Pick, pack and ship fee (1)
  Monthly distribution account management fee (6)
	 
	$ [***]
	 
	Per month

	Ambient product pick / pack / stage (Includes sales rep samples)
	 
	$ [***]
	 
	Per line per first case

	Ambient product pick / pack / stage (Includes sales rep samples)
	 
	$ [***]
	 
	Per each additional case

	Freight Charges
	 
	Cost plus [***]% handling fee
	 
	 

	Packing/Shipping materials (4)
	 
	Cost plus [***]% handling fee
	 
	 

	Destruction Charges
	 
	Cost plus [***]% handling fee
	 
	Per order

	Exclusive Pharmaceutical Transportation Network (EPTN)
	 
	$ [***]
	 
	Per CFT + FSC

	Emergency / International Orders
	 
	$ [***]
	 
	Per order

	Rep Samples
	 
	 
	 
	 

	Sample management fee
	 
	$ [***]
	 
	Per month

	Sample product pick/pack/stage
	 
	$ [***]
	 
	Per line

	Sample product pick/pack/stage
	 
	$ [***]
	 
	Per pick

	Sample per order processing fee
	 
	$ [***]
	 
	Per order

	Practitioner Samples
	 
	 
	 
	 

	Sample product pick/pack/stage
	 
	$ [***]
	 
	Per line

	Sample product pick/pack/stage
	 
	$ [***]
	 
	Per pick

	Sample per order processing fee
	 
	$ [***]
	 
	Per order

	AOC/AOD fee
	 
	$ [***]
	 
	Per order

	Clinical Trials
	 
	 
	 
	 

	Clinical product pick/pack/stage
	 
	$ [***]
	 
	Per line

	Clinical product pick/pack/stage
	 
	$ [***]
	 
	Per pick

	Clinical per order processing fee
	 
	$ [***]
	 
	Per order

	Information System
  System access and support fee (2)
	 
	$ [***]
	 
	Per month

	Special reports, connectivity or other IT requests (per hour charge)
	 
	$ [***]
	 
	Per hour

	Customer Service
  Customer Service Management fee
	 
	$ [***]
	 
	Per month

	Per order processing fee (Includes sales rep samples)
	 
	$ [***]
	 
	Per order

	Per credit memo
	 
	$ [***]
	 
	Per credit memo

	Financial Services
  Accounts Receivable Management Fee
	 
	$ [***]
	 
	Per month

	
					
	AR per order processing fee
	 
	$ [***]
	 
	Per order

	Chargeback Management fee
	 
	$ [***]
	 
	Per month (0 - 50 lines)

	Chargeback Management fee
	 
	$ [***]
	 
	Per month (51 - 100 lines)

	Chargeback Management fee
	 
	$ [***]
	 
	Per month ( 101+ lines)

	Chargeback per line fee
	 
	$ [***]
	 
	Per line

	Secondary Distribution Services (7)
  Warehouse management fee (6)
	 
	$ [***]
	 
	Per month

	Ambient storage fee (5)
	 
	$ [***]
	 
	Per pallet per month

	 
	 
	 
	 
	 

	Return Services
	 
	 
	 
	 

	Return Storage Fees
	 
	 
	 
	 

	Ambient storage fee
	 
	$ [***]
	 
	Per pallet per month

	Returns management fee
	 
	$ [***]
	 
	Per month

	Processing of units - includes RA process, includes receipt and processing of return unit, includes Return and Credit memo issuance
	 
	$ [***]
	 
	Per piece

	Processing of unopened cases
	 
	$ [***]
	 
	Per case

	Check processing
	 
	$ [***]
	 
	Each

	Product destruction (fuel surcharge, trans fee, and per pound fee)
	 
	 
	 
	at Cost Pass through - NO MARK-UP

	Recall Management
	 
	 
	 
	 

	Recall Setup
	 
	$ [***]
	 
	One time setup fee

	Processing fees will be the same as regular product
	 
	 
	 
	 

	Recall Support
	 
	$ [***]
	 
	Per hour

	 
	 
	 
	 
	 

Note (1): This amended fee schedule is based on distribution services for Cumberland Pharmaceuticals.
Note (2): System access fees includes five user logins to the SmartData reporting system. Additional users will increase the monthly fee by $[***] per user. The system access fee also supports the collection, maintenance and housing of data and IT staff support of the Cardinal Health systems supporting Client's business (i.e. Elite WMS and DMS) * Information Systems / Smart Data fixed fee will increase to $[***] from current $[***] after sample line launches. 
Note (3): Should Cumberland Pharmaceuticals require an additional product or service implementation, excluding the product/SKU noted, SPS reserves the right to assess additional Program Implementation Fees. The first payment would be due after the initial implementation meeting. In addition distribution, customer service and financial service monthly fees could be increased accordingly per implementation.
Note (4): Supplies include boxes, tape, labels, bubble pack, etc (approx. $[***] per shipment), pallets ($[***]/pallet), and any other Cumberland Pharmaceuticals requirements.
Note (5): Pallet storage fee is based on a daily average of pallets on hand. Pallet storage greater than two months inventory on hand will be assessed an additional charge of three times the standard fee.
Note (6): The account management fee covers the following services: logistics management, inventory management, regulatory affairs and quality assurance, receiving discrepancy resolution, standard operating procedures, validation management, supply control, process set-ups, and process scheduling.
Note (7): Cardinal SPS will provide business continuity and third party logistics services including product storage and distribution management from its Reno, Nevada facility. All other fees for pick/pack/stage, order, credit 

memo, invoice and chargeback processing will be applied accordingly to product that is shipped out of the Reno, Nevada facility.
Note (8): Payment terms will be Net [***].
	
			
	/s/ Walter V. Worsham, 5/22/2013
	 
	Rick S. Greene, CFO, 5/20/13

	Cardinal SPS Finance Manager Signature/Date
	 
	Client Acceptance Signature/Title/Date

	 
	 
	 

	/s/ Sanjeeth Pai, 5/22/13
	 
	 

	Cardinal SPS VP Signature/Dateexh10_1.htm

 

Exhibit 10.1

 

GSI TECHNOLOGY, INC.

2014 VARIABLE COMPENSATION PLAN

(Effective as of April 1, 2013)

 

 1.  Introduction.  The Company hereby adopts the Plan, effective as of April 1, 2013.  The purpose of the Plan is to encourage performance and achieve retention of a select group of executive employees of GSI Technology, Inc.  This document constitutes the written instrument under which the Plan is maintained.

 

 2.  Definitions.

 

  “Cause” means (i) conviction of a felony or a crime of moral turpitude; (ii) misconduct that results in harm to the Company; (iii) material failure to perform assigned duties; or (iv) willful disregard of lawful instructions from the chief executive officer of the Company or the Board of Directors relating to the business of the Company or any of its affiliates.

 

  “Code” means the Internal Revenue Code of 1986, as amended, and the regulations issued with respect thereof.

 

  “Committee” means the Compensation Committee of the Company’s Board of Directors.

 

  “Company” means GSI Technology, Inc., a Delaware corporation.

 

  “Disability” means that a Participant (i)  is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (ii)  is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering employees of the Participant’s employer.

  “Eligible Employee” means each employee who is eligible for the Plan as designated by the Committee as set forth in approved minutes.

 

  “Operating Income” means the Company’s operating income for fiscal 2014, excluding (1) share based compensation, (2) acquisition-related costs , (3) patent/IP related litigation costs and (4) any adjustments as deemed necessary by the Committee for 2014.

 

  “Normal Retirement Age” means age sixty (60).

 

  “Participant” means each Eligible Employee who is designated from time to time by the Committee in writing.

 

  “Plan” means the GSI Technology, Inc. 2014 Variable Compensation Plan, as set forth in this document and as hereafter amended.

 

  “Retirement” means the termination of employment after Normal Retirement Age.

 

 3.  Variable Compensation Award.

 

(a) Variable Compensation Award and Calculation of Payable Amount. Each Participant will receive an award, entitling the Participant to earn variable compensation, the payment of which will be based upon (i) the achievement of performance criteria based on Operating Income and net revenues determined in accordance with US GAAP, or a combination of the two and (ii) continued employment by the Participant through the vesting dates set forth in Section 4 hereof (the “Variable Compensation Award”).  The Committee shall designate in writing the amount payable under the Variable Compensation Award and, if applicable, the percentage of the amount payable under the Variable Compensation Award that is allocable to each of the criteria.  Notwithstanding the foregoing, the maximum amount payable under a Variable Compensation Award granted to any Participant shall not exceed two times the Participant’s target Variable Compensation Award for 2014, unless the Committee, in its sole discretion, decides to permit a greater amount with respect to such Participant based on the performance and condition of the Company’s business. Also, at any time prior to April 1, 2014, the Committee or the CEO, in his, her, or its sole discretion, may reduce the amount payable under any Participant’s Variable Compensation Award.  The amount of the Variable Compensation Award that may become payable to the extent it becomes vested in accordance with the schedule set forth in Section 4 hereof shall be calculated as soon as reasonably practicable following April 1, 2014 based on the extent to which the performance criteria set forth in this Section 3(a) have been achieved (the “Award Payment Amount”).

 

  

  

  

 

 

4.  Payment of Variable Compensation Award.

 

(a)  Vesting, Timing and Form of Payment. Subject to Sections 4(b), 4(c), 4(d) and 7, each Participant’s Award Payment Amount shall vest and be paid as follows:

 

(i)  Sixty percent (60%) of the Participant’s Award Payment Amount shall vest and be paid to the Participant on the last business day in April 2014; and

 

(ii)  Twenty percent (20%) of the Participant’s Award Payment Amount (i.e. fifty percent (50%) of the Award Payment Amount then remaining) shall vest and be paid to the Participant on the last business day in April, 2015; and

 

(iii)  Twenty percent (20%) of the Participant’s Award Payment Amount (i.e. one-hundred percent (100%) of the Award Payment Amount then remaining) shall vest and be paid to the Participant on the last business day in April, 2016.

 

(b)  Distribution in the Event of Retirement, Termination as a result of Disability or without Cause. If a Participant terminates employment because of Retirement or Disability, or the Company terminates a Participant’s employment without Cause, the Participant shall be entitled to payment of all of his or her Award Payment Amount according to the schedule in Section 4(a), provided that if termination under these conditions occurs prior to April 1, 2014, the amount of the Variable Compensation Award payable will be the Award Payment Amount calculated pursuant to Section 3(a), multiplied by the number of days employee was employed in Fiscal 2014 by the Company and then divided by 365 days, and all remaining amounts payable under Variable Compensation Award for 2014 shall be forfeited.

 

(c)  Forfeiture. If the Company terminates a Participant’s employment for Cause or if the Participant’s employment is terminated for any reason other than as a result of Retirement or Disability, he or she shall forfeit all or any portion of his or her entire Award Payment Amount for 2014 (as set forth in Section 3(a)) which is not yet vested and payable under the schedule set forth in Section 4(a) as of the date of termination.

 

(d)  Timing of Distribution to a Beneficiary. If a Participant dies while still employed by the Company or after termination due to Retirement, Disability, or termination by the Company without Cause but before receiving a distribution of all of his or her Award Payment Amount according the schedule in Section 4(a), then the vesting of the Participant’s Award Payment Amount shall be fully accelerated such that one-hundred percent (100%) of the Award Payment Amount, as calculated pursuant to Section 4(b) hereof (with the amount prorated to the date of death in the event death occurs prior to April 1, 2014), will be distributed to his or her beneficiary as a lump sum distribution on the April 30 following the Participant’s death.

 

 

  

  

  

 

 

(e)  Beneficiary Designation. Each Participant must designate a beneficiary to receive a distribution of his or her Variable Compensation Award if the Participant dies before such amount is fully distributed to him or her. To be effective, a beneficiary designation must be signed, dated and delivered to the Committee. In the absence of a valid or effective beneficiary designation, the Participant’s surviving spouse will be his or her beneficiary or, if there is no surviving spouse, the Participant’s estate will be his or her beneficiary. If a married Participant designates anyone other than his or her spouse as his or her beneficiary, such designation will be void unless it is signed and dated by the Participant’s spouse.

 

5.  Withholding. The Company will withhold from any Plan distribution all required federal, state, local and other taxes and any other payroll deductions that may be required.

 

6.  Administration. The Plan is administered and interpreted by the Company. The Company has delegated to the Committee certain responsibilities under the Plan. The Committee has the full and exclusive discretion to interpret and administer the Plan. All actions, interpretations and decisions of the Committee are conclusive and binding on all persons, and will be given the maximum possible deference allowed by law.  Subject to the provisions of the Plan, the Committee shall have full authority to select, in its sole discretion the Participant to whom Variable Compensation Awards will be granted.

 

7.  Amendment or Termination. Through March 31, 2014, the Committee, in its sole and unlimited discretion, may amend or terminate the Plan at any time, without prior notice to any Participant. After April 1, 2014, the Committee may amend or terminate the Plan provided that any such amendment does not reduce or increase any benefit to which a Participant has accrued and is otherwise entitled to under the terms of the Plan, nor accelerate the timing of any payment under the Plan. Notwithstanding the foregoing to the contrary, the Company reserves the right to the extent it deems necessary or advisable, in its sole discretion, to unilaterally alter or modify the Plan and any Variable Compensation Awards made thereunder to ensure that the Plan and Variable Compensation Awards provided to Participants who are U.S. taxpayers are made in such a manner that either qualify for exemption from or comply with Code Section 409A; provided, however, that the Company makes no representations that the Plan or any Variable Compensation Awards made thereunder will be exempt from or comply with Code Section 409A and makes no undertaking to preclude Code Section 409A from applying to the Plan or any Variable Compensation Awards made thereunder. The Plan shall automatically terminate on the date when no Participant (or beneficiary) has any right to or expectation of payment of further benefits under the Plan.

 

8.  Source of Payments. All payments under the Plan will be paid in cash from the general funds of the Company. No separate fund will be established under the Plan, and the Plan will have no assets. Any right of any person to receive any payment under the Plan is no greater than the right of any other general unsecured creditor of the Company. This Plan shall be binding upon the Company’s successors and assigns.

 

9.  Inalienability. A Participant’s rights to benefits under the Plan are not subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment by creditors of the Participant or the Participant’s beneficiary.

 

10.  Applicable Law. The provisions of the Plan will be construed, administered and enforced in accordance with the laws of the State of California without reference to its principles of conflicts-of-laws.

 

11.  Severability. If any provision of the Plan is held invalid or unenforceable, its invalidity or unenforceability will not affect any other provision of the Plan, and the Plan will be construed and enforced as if such provision had not been included.

 

12.  No Right of Continued Employment. THIS PLAN DOES NOT GIVE ANY ELIGIBLE EMPLOYEE OR PARTICIPANT THE RIGHT TO BE RETAINED AS AN EMPLOYEE. SUBJECT TO THE TERMS OF ANY WRITTEN EMPLOYMENT AGREEMENT TO THE CONTRARY, THE COMPANY SHALL HAVE THE RIGHT TO TERMINATE OR CHANGE THE TERMS OF EMPLOYMENT OF AN ELIGIBLE EMPLOYEE OR A PARTICIPANT AT ANY TIME AND FOR ANY REASON WHATSOEVER, WITH OR WITHOUT CAUSE.

 

 

  

  

  

 

13.  Bindings on Successor.  The liabilities and obligations of the Company under this Plan will be binding upon any successor corporation or entity which succeeds to all or substantially all of the assets and business of the Company by merger or other transaction.

 

IN WITNESS WHEREOF, GSI Technology, Inc., by its duly authorized officer, has executed the Plan on the date indicated below.

 

 

GSI TECHNOLOGY, INC.

 

/s/ Lee-Lean She

Name: Lee-Lean Shu

Title: Chief Executive Officer

Date:______________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]